Epigenetic regulation of protein phosphatase 2A (PP2A), Lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells
暂无分享,去创建一个
[1] S. Pavey,et al. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. , 2004, International journal of cancer.
[2] S. Weitzman,et al. Hypermethylation of a Small CpGuanine-Rich Region Correlates with Loss of Activator Protein-2α Expression during Progression of Breast Cancer , 2004, Cancer Research.
[3] Dipali Sharma,et al. A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine , 2003, Breast Cancer Research and Treatment.
[4] Tim Hui-Ming Huang,et al. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. , 2003, Cancer research.
[5] P. Keng,et al. THY1 expression is associated with tumor suppression of human ovarian cancer. , 2003, Cancer genetics and cytogenetics.
[6] Tim Hui-Ming Huang,et al. Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. , 2003, Cancer research.
[7] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[8] A. Davidoff,et al. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma. , 2003, Blood.
[9] N. Davidson,et al. The biology of breast carcinoma , 2003, Cancer.
[10] Long-Cheng Li,et al. MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..
[11] H. Yao,et al. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer , 2002, Journal of Molecular Medicine.
[12] Tim Hui-Ming Huang,et al. Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. , 2002, Cancer research.
[13] R. Pili,et al. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. , 2002, Cancer research.
[14] H. Hamada,et al. Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100 , 2002, Gene Therapy.
[15] A. Bird. Methylation Talk Between Histones and DNA , 2001, Science.
[16] J. Herman,et al. Synergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells , 2001 .
[17] D. McDonnell,et al. The Human Estrogen Receptor-α Is a Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and Selective Estrogen Receptor Modulators* , 2001, The Journal of Biological Chemistry.
[18] J. Barrett,et al. Suppression of tumorigenicity in human ovarian carcinoma cell line SKOV-3 by microcell-mediated transfer of chromosome 11. , 2001, Cancer genetics and cytogenetics.
[19] C. Allis,et al. Translating the Histone Code , 2001, Science.
[20] J. Herman,et al. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. , 2000, Cancer research.
[21] S. Zołnierowicz. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. , 2000, Biochemical pharmacology.
[22] C. Allis,et al. Acetylation and chromosomal functions. , 2000, Current opinion in cell biology.
[23] A. Bird,et al. Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.
[24] R. Clarke,et al. Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status. , 1999, Cancer letters.
[25] A. Razin,et al. CpG methylation, chromatin structure and gene silencing—a three‐way connection , 1998, The EMBO journal.
[26] Colin A. Johnson,et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.
[27] S. Baylin,et al. Role of Estrogen Receptor Gene Demethylation and DNA Methyltransferase·DNA Adduct Formation in 5-Aza-2′deoxycytidine-induced Cytotoxicity In Human Breast Cancer Cells* , 1997, The Journal of Biological Chemistry.
[28] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Weitzman,et al. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] S. Baylin,et al. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.
[31] S. Baylin,et al. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.
[32] Alan P. Wolffe,et al. A positive role for histone acetylation in transcription factor access to nucleosomal DNA , 1993, Cell.
[33] A. Bird. CpG-rich islands and the function of DNA methylation , 1986, Nature.
[34] Matty P. Weijenberg,et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.
[35] T. Bestor,et al. DNA methyltransferases. , 1994, Current opinion in cell biology.
[36] T. Bestor,et al. Cloning of a mammalian DNA methyltransferase. , 1988, Gene.